““From the start of the project, Enlight brought a sound understanding of biology allied to a creativity to bring our scientific concepts to life. The team were highly interactive and responsive to suggestions whilst sharing the benefit of their experience. With an attention to detail to ensure the scientific content was accurately displayed whilst making it an engaging story, Enlight proved to be a great partner for Storm Therapeutics to convey our work to a broad customer audience.” Keith Blundy CEO Storm Therapeutics.
Omega Insights GmbH acquired Enlight Medical Ltd. on 1 April 2019. Enlight Medical has been integrated into Omega Insights under the Enlight Science brand.
Select the Omega Insights logo for information about global branding services.
Select the Enlight Science logo for information about digital creative services.